Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers Results available

Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Older Adults

ClinicalTrials.gov ID: NCT05297578

Public ClinicalTrials.gov record NCT05297578. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 1:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Observer-Blind, Dose-Finding, Controlled Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Healthy Adults 65 Years and Older

Study identification

NCT ID
NCT05297578
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Vaxcyte, Inc.
Industry
Enrollment
207 participants

Conditions and interventions

Interventions

  • 24-Valent Pneumococcal Conjugate Vaccine Biological
  • Pneumococcal 20-valent Conjugate Vaccine Biological

Biological

Eligibility (public fields only)

Age range
65 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 14, 2022
Primary completion
Feb 14, 2023
Completion
Feb 14, 2023
Last update posted
Oct 8, 2024

2022 – 2023

United States locations

U.S. sites
20
U.S. states
14
U.S. cities
20
Facility City State ZIP Site status
Accel Research Sites-Birmingham Clinical Research Unit Birmingham Alabama 35216
Accel Research Sites - DeLand Clinical Research Unit DeLand Florida 32720
CenExel RCA Hollywood Florida 33024
Precision Clinical Research Sunrise Florida 33351
Meridian Clinical Research Savannah Georgia 31406
Pivotal Research Solutions Stonecrest Georgia 30038
Healthcare Research Network II, LLC Flossmoor Illinois 60422
AMR Newton, formerly Heartland Research Associates Newton Kansas 67114
AMR Wichita West Wichita Kansas 67205
AMR New Orleans New Orleans Louisiana 70119
Healthcare Research Network Hazelwood Missouri 63042
Meridian Clinical Research Omaha Nebraska 68134
Accellacare of Rocky Mount Rocky Mount North Carolina 27804
Meridian Clinical Research Cincinnati Ohio 45219
Accellacare of Charleston Mt. Pleasant South Carolina 29464
Coastal Carolina Research North Charleston South Carolina 29405
Clinical Trials of Texas, LLC San Antonio Texas 78229
CenExel JBR Clinical Research Salt Lake City Utah 84107
Velocity Clinical Research, Salt Lake City West Jordan Utah 84088
Charlottesville Medical Research Charlottesville Virginia 22911

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05297578, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 8, 2024 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05297578 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →